New Biomarker Candidates of Sepsis: Diagnostic and Prognostic Value of Presepsin, Angiopoietin 1 and 2

Hamit Yıldız; Nuray Gül Açar

doi:10.58600/eurjther2090

Authors

Hamit Yıldız Department of Internal Medicine, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye https://orcid.org/0000-0001-7858-5123
Nuray Gül Açar Department of Hematology, Faculty of Medicine, Çukurova University, Adana, Türkiye https://orcid.org/0000-0002-5079-3593

DOI:

https://doi.org/10.58600/eurjther2090

Keywords:

Sepsis, Presepsin, Angiopoitein I, Angiopoietin II

Abstract

Objective: Sepsis is an uncontrolled inflamatory response that occurs in the body towards infection. It’s an important clinical picture that is seen in high morbidity and mortality so early diagnose and treatment areimportant. For that reason, for the septic cases to get early diagnosis and to predict the prognosis, new biomarkers are needed nowadays. Presepsin, angiopoietin 1 and angiopoietin II are biomarkers that are not usedroutinely yet, in our study, according to the new description given in Sepsis 3 meeting, in cases that are diagnosed with sepsis, we aimed at comparing diagnostic and prognostic values of these biomarkers.

Methods: In our study, there were two groups. Patient group consisting of 48 cases with 33 men and 15 women and control group consisting of 42 cases with 23 men and 19 women. Control group is selected within patient relatives with similarities of age and sex. Demographic datas, accompanying diseases, APACHE II, SAPS and SOFA scores counted in the first 24 hours, leukocyte count, eritrocyte sedimentation rate, C-reactive protein, procalcitonin value, culture sampling results (blood, urine, sputum, endotracheal aspirate) that are measured in their stays, 7th and 28th day mortality counts after their ICU stays are written down. Presepsin, angiopoietin I and angiopoietin II are detected by sandwich ELISA method.

Results: According to demographic features there isn’t any significant statistical difference between the patient group and the control group (p>0.005). In patient group Presepsin, angiopoietin I and angiopoietin II values were statistically high significantly compared to the control group (p<0.001). After the evaluation, serumpresepsin value noticed that has a diagnostic value in the diagnosis of sepsis (EAA: 0.74, 95%GA: 0.64–0.85, p<0.001). The suggested border value for this value is predicted as 0.47, 73%sensitivity and 62% specificity are determined. Serum angiopoietin I value noticed that has a diagnostic value in the diagnosis of sepsis (EAA: 0.80, 95%GA: 0.71–0.89, p<0.001). The suggested border value for this value is predicted as 178.24, 69% sensitivity and 69% specificity are determined. Serum angiopoietin II value noticed that has a diagnostic value in the diagnosis of sepsis (EAA: 0.89, 95% GA: 0.82–0.95, p<0.001). The suggested border value for this value is predicted as 77.56, 84% sensitivity and 83% specificity are determined.

Conclusions: In our study, presepsin, angiopoietin I and angiopoietin II values are determined as statistically high according to healthy control group and are found successful with high sensitivity and specificity in diagnosing. Presepsin, angiopoietin I and angiopoietin II values in septic patients are found successful with high sensitivity and specificity at 7th and 28th days mortality prediction.

Metrics

Metrics Loading ...

References

Neviere R, Gong MN, Finlay G. Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis. Access date: 03.01.2020. https://www.medilib.ir/uptodate/show/1657

Abraham E. New Definitions for Sepsis and Septic Shock: Continuing Evolution but With Much Still to Be Done. JAMA. 2016 Feb 23;315(8):757-9. https://doi.org/10.1001/jama.2016.0290

Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 Jul;29(7):1303-10. https://doi.org/10.1097/00003246-200107000-00002

Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637. https://doi.org/10.1097/CCM.0b013e31827e83af

Sakr Y, Jaschinski U, Wittebole X, et al. ICON Investigators. Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit. Open Forum Infect Dis. 2018 Nov 19;5(12): ofy313. https://doi.org/10.1093/ofid/ofy313

Stoller J, Halpin L, Weis M, et al. Epidemiology of severe sepsis: 2008-2012. J Crit Care. 2016 Feb;31(1):58-62. https://doi.org/10.1016/j.jcrc.2015.09.034

Hajj J, Blaine N, Salavaci J, et al. The "Centrality of Sepsis": A Review on Incidence, Mortality, and Cost of Care. Healthcare (Basel). 2018 Jul 30;6(3):90. https://doi.org/10.3390/healthcare6030090

Page DB, Donnelly JP, Wang HE. Community-, Healthcare-, and Hospital-Acquired Severe Sepsis Hospitalizations in the University HealthSystem Consortium. Crit Care Med. 2015 Sep;43(9):1945-51. https://doi.org/10.1097/CCM.0000000000001164

Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. https://doi.org/10.1001/jama.2016.0287

Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010 Oct 27;304(16):1787-94. https://doi.org/10.1001/jama.2010.1553

Zhang X, Liu D, Liu YN, et al. The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis. Crit Care. 2015 Sep 11;19(1):323. https://doi.org/10.1186/s13054-015-1032-4

Engel C, Brunkhorst FM, Bone HG, et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 2007 Apr;33(4):606-18. https://doi.org/10.1007/s00134-006-0517-7. Epub 2007 Feb 24. PMID: 17323051.

Escarce JJ, Kelley MA. Admission source to the medical intensive care unit predicts hospital death independent of APACHE II score. JAMA. 1990 Nov 14;264(18):2389-94.

Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001 Oct 10;286(14):1754-8. https://doi.org/10.1001/jama.286.14.1754

Vincent JL, Opal SM, Marshall JC. Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med. 2010 Jan;38(1):283-7. https://doi.org/10.1097/CCM.0b013e3181b785a2

Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004 Jul 15;39(2):206-17. https://doi.org/10.1086/421997. Epub 2004 Jul 2. Erratum in: Clin Infect Dis. 2005 May 1;40(9):1386-8.

Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004 Jul 15;39(2):206-17. https://doi.org/10.1086/421997

Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, Nishida T, Irie Y, Miura M, Iguchi H, Fukui Y, Tanaka K, Nojima T, Okamura Y. Uselfulness of Presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012; 18(6):891-897

Liu B, Chen YX, Yin Q, et al. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care. 2013 Oct 20;17(5): R244. https://doi.org/10.1186/cc13070

Kondo Y, Umemura Y, Hayashida K, et al. Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis. J Intensive Care. 2019 Apr 15;7: 22. https://doi.org/10.1186/s40560-019-0374-4

Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999 May 1;13(9):1055-66. https://doi.org/10.1101/gad.13.9.1055

Melendez E, Whitney JE, Norton JS, et al. Systemic Angiopoietin-1/2 Dysregulation in Pediatric Sepsis and Septic Shock. Int J Med Sci. 2019 Jan 1;16(2):318-323. https://doi.org/10.7150/ijms.27731

König M, Nentwig A, Marti E, et al. Evaluation of plasma angiopoietin-2 and vascular endothelial growth factor in healthy dogs and dogs with systemic inflammatory response syndrome or sepsis. J Vet Intern Med. 2019 Mar;33(2):569-577. https://doi.org/10.1111/jvim.15369

Gutbier B, Neuhauß AK, Reppe K, et al. CAPNETZ and PROGRESS Study Groups ‡. Prognostic and Pathogenic Role of Angiopoietin-1 and -2 in Pneumonia. Am J Respir Crit Care Med. 2018 Jul 15;198(2):220-231. https://doi.org/10.1164/rccm.201708-1733OC

Zonneveld R, Jongman R, Juliana A, et al. Low Serum Angiopoietin-1, High Serum Angiopoietin-2, and High Ang-2/Ang-1 Protein Ratio are Associated with Early Onset Sepsis in Surinamese Newborns. Shock. 2017 Dec;48(6):638-643. https://doi.org/10.1097/SHK.0000000000000903